CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Medical Devices & Global External Innovation

Aaron Goodstein, Senior Director, Medical Safety Operations

The Importance of Independent Safety Input into the Medical Devices R&D Process

Aaron Goodstein

Aaron Goodstein

Medical device development follows a well-established path. Many of these steps overlap with each other as scientists and researchers invent, refine and test the devices to evaluate both efficacy and patient safety. Design reviews are an essential part of the medical device design process. They are conducted during various stages of the design process to ensure that the device remains safe and complete during every stage of its development. It is the responsibility of the manufacturer or designer to plan and prepare for these reviews. Design reviews need to be performed by individuals with an objective lens to ensure a fair analysis of the medical device design and development process, to build the safest possible device and improve patient outcomes. For this reason, it is critical that there are independent reviewers who are unbiased and have a knowledge of the technical aspects of the product participating in the process.


The independent medical safety function can also play a key role in the safety oversight of clinical trials and other means of clinical evidence generation


Traditionally, independence is defined as being independent from the project under review. However, a more holistic definition of independence should include independence from the commercial and R&D organizations responsible for the timeline and business outcomes. This type of reporting structure further removes the potential for unintended commercial pressure and the unconscious developer bias it may impart on the review process.


In addition to the concept of independence, a key technical area that is sometimes overlooked is the medical safety aspects, from user need through design realization. An independent medical safety organization can help bring a unique perspective around pathology, user needs and an ability to speak on behalf of the patients they have treated over the course of their clinical careers.


While design frequently incorporates independent reviewers from an engineering perspective, having an independent medical voice during this process may provide invaluable insight that allows teams to identify potential challenges to design validations and safety concerns earlier in the project. This has the potential to reduce overall cycle time for product development and decrease post-market issues – and also to promote optimal patient safety outcomes. An independent medical organization that has responsibility for the oversight of products throughout the product lifecycle is positioned to bring knowledge from not only their clinical experience but from the performance of predicate or similar devices to the design team early in the development process.


The independent medical safety role may support the R&D organization during product development through inputs and reviews of various deliverables throughout the development process. In the pre-clinical space, independent medical safety review of identified user needs, verification and validation plans ensures that the reviews of residual risk throughout the project are not inadvertently influenced by any bias. The independent medical safety function can also play a key role in the safety oversight of clinical trials and other means of clinical evidence generation.


Design reviews have always included a level of independent engineering review of the technical aspect of the product, but whether or not those engineers are truly independent remains a question in the R&D process. Device manufacturers may benefit from incorporating an independent medical safety review that focuses on the safety elements of the device and emphasizes the importance of the safety of the device. Striving for true independence within the medical devices design process can help promote the safety of patients around the globe.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://life-science-marketing-europe.lifesciencesreview.com/leadership-perspective/the-importance-of-independent-safety-input-into-the-medical-devices-rd-process-nwid-899.html